New AI capabilities will help scientists identify, optimize, and validate new molecules. Additional applications include manufacturing, medical imaging, and enterprise AI agents
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
This innovative solution comes as an answer to the industry-wide challenges of availability, cost, and dependencies linked to custom and proprietary hardware components
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
The platform integrates with CT imaging and uses deep learning models to generate a 3D digital twin of lung anatomy
StarGuide GX delivers ultra-high sensitivity and high-resolution imaging, enabling fast, confident diagnostics
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data
The startup’s AI platform uses AI algorithms to automatically detect abnormalities and diseases in medical images, reducing patient misdiagnosis and increasing radiologists’ productivity
Subscribe To Our Newsletter & Stay Updated
